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Abstract
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Background: Clinicians often express concerns about poor sensitivity of blood cultures in
neonates resulting from inadequate inoculant volumes. Our objective was to determine the
inoculant volume sent for neonatal sepsis evaluations and identify areas of improvement.
Methods: Single-center prospective observational study of infants undergoing sepsis evaluation.
Blood volume was determined by clinician-documentation over 21 months, and additionally
by weighing culture bottles during 12 months. Adequate volume was defined as ≥1 mL total
inoculant per evaluation. For first-time evaluations, local guidelines recommend sending an
aerobic-anaerobic pair with 1 mL inoculant in each.
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Results: There were 987 evaluations in 788 infants. Clinicians reported ≥1 mL total inoculant
in 96.9% of evaluations. Among 544 evaluations where bottles were weighed, 93.4% had ≥1 mL
total inoculant. Very low birth weight infants undergoing evaluations >7 days after birth had the
highest proportion of inadequate inoculants (14.4%). Only 3/544 evaluations and 26/1,011 bottles
had total inoculant <0.5 mL. Ninety evaluations had <1 mL in both aerobic and anaerobic bottles
despite a total inoculant volume that allowed inoculation of ≥1 mL in one of the bottles.
Conclusions: Obtaining recommended inoculant volumes is feasible in the majority of neonates.
Measuring inoculant volumes can focus improvement efforts and improve test reliability.

INTRODUCTION
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Blood culture is a common test among infants admitted to the neonatal intensive care
unit (NICU), and is important in diagnosing bacteremia and in ensuring accurate antibiotic
therapy.(1, 2) Reliability of blood culture results depends on the inoculant volume with 1 mL
blood volume recommended as adequate inoculant for neonates.(3–6) However, insufficient
inoculant volumes have been reported in both adult and pediatric settings.(7–11) Given
these reports, neonatal clinicians express concern about the reliability of blood culture
tests resulting in frequent diagnosis of ‘culture-negative sepsis’,(12–14) and prolonged use
of empiric antibiotics in neonatal units.(15–17) Four studies have objectively measured
inoculant volumes specifically in neonates and report rates of inadequate inoculants varying
from 33% to over 90% of all cultures sent.(7, 9, 10, 18) Potential reasons for inadequate
inoculant volume include technical difficulty obtaining blood,(10, 18) concerns regarding
the hemodynamic impact of acute volume loss, contribution of iatrogenic blood loss
to neonatal anemia,(19, 20) and the differing recommendations for optimal inoculant
volume.(20) These challenges have made clinicians question whether consistently obtaining
adequate inoculant volumes is feasible,(10) and are deterrents to accepting blood culture
results when negative.(7, 13, 14, 21)
As part of local antibiotic stewardship efforts, our center has developed written guidelines,
provided clinician education and mandated the use of real-time documentation for blood
culture procedures. The objective of this study was to determine the frequency with which
our center was obtaining ≥1 mL inoculant for blood culture tests, and identify clinical
scenarios or technical issues associated with inadequate inoculant volumes.

MATERIALS AND METHODS
Study Design:

Author Manuscript

Prospective observational single-center study.
Setting and Population:
Pennsylvania Hospital NICU is a 50-bed Level 3, high-risk perinatal center. All neonates
admitted to the NICU with orders placed for blood culture between 12/01/2017 and
8/31/2019 were included in the study. This study was approved with waiver of consent
by the Institutional Review Board at the University of Pennsylvania.
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Clinicians at our center identified reliable blood culture results as a key component
of antibiotic stewardship. Consistent documentation of the blood culture procedure was
required to allow the information to be incorporated into decision-making regarding
antibiotic use and clinical care. We created a standardized format for the blood culture
procedure note in the electronic medical record. Because the clinician obtaining the blood
sample is often different from the nurse inoculating the culture bottle, we chose to weigh
the bottles to accurately determine inoculant volume. Education about optimal technique
for obtaining blood cultures was provided to clinicians at study initiation. Interim results
from the weighing procedure were provided to clinicians at several timepoints during the
study. Supplemental Figure S1 (online) provides a timeline for specific study interventions
along with monthly blood culture numbers and monthly percent positive cultures (excluding
commensal contaminants and repeat positive cultures).
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Blood culture guidelines:
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Inoculant measurement:

Center guidelines recommend that 2 mL total blood be obtained for blood culture tests
sent in an initial sepsis evaluation, with 1 mL inoculated into a single pediatric aerobic
(BD Bactec™ Peds Plus/F) and 1 mL into a single anaerobic (BD Bactec™ Lytic/10
Anaerobic/F) bottle. For confirmed infection, 1 mL blood inoculated into an appropriate
culture bottle to ensure resolution of bacteremia is sufficient. Blood is obtained after
aseptic preparation by venous or arterial phlebotomy or by withdrawing blood from a
central catheter. If difficulties arise with obtaining blood for initial evaluation, guidelines
recommend that a minimum of 1 mL be cultured, ideally in an aerobic bottle. Therefore, the
minimum inoculant considered adequate in this study was 1 mL, in either a single bottle or
divided between two culture bottles.

As part of routine clinical care, clinicians obtaining the specimen are required to write a
procedure note in the electronic medical record system (Epic Systems Corporation, Verona,
WI) documenting the following in real-time: (a) total volume obtained, (b) number and
type of bottles submitted for culture, (c) blood source (phlebotomy or catheter), and (d)
the number of phlebotomy attempts, if applicable. Data from these procedure notes was
abstracted from the medical records Monday through Friday. Clinicians were contacted to
obtain missing or incomplete data.
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From 8/30/2018 to 8/31/2019, blood culture bottles were additionally weighed before
and after inoculation to objectively determine inoculant volume. Culture bottles were preweighed (to obtain accurate tare weight) by research staff in batches of 10–15 and stored onsite in the NICU. When a blood culture test was ordered, the NICU charge nurse recorded
the pre-inoculation weight written on the culture bottle, provided the bottle to the clinical
team, and re-weighed the bottle (with cap) immediately after inoculation. All weights were
obtained with a Sartorius precision balance (margin of error, ±10−4 gram) (Sartorius AG,
Göttingen, Germany). Inoculant volume was calculated by dividing the difference in preand post-inoculation bottle weights by 1.0581, the density of blood.(22)
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Patient data were abstracted from the electronic medical records. Culture-confirmed
infection was defined as growth of a pathogen from at least one blood culture bottle.
Micrococcus, Propionibacterium, Corynebacterium, and Bacillus species were considered
contaminants. Coagulase-negative staphylococci were considered pathogens if treated by the
clinical team with an appropriate course of antibiotics.
Analysis:
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We defined total inoculant volume as the blood volume obtained per sepsis evaluation,
which may be inoculated into a pair of aerobic and anaerobic bottles or a single bottle. We
calculated the proportion of evaluations with adequate inoculant by clinician report and by
weight. We also report inoculant volume per bottle for evaluations completed during the
12 months when bottles were weighed. Inoculant volume assessed by weight was retained
at 10−4 precision for all calculations and rounded to 10−2 only for presentation. Birth
weight and chronological age influences frequency of blood culture orders(23) and presence
of central lines, which can in turn affect the source of inoculant collection. Therefore,
we analyzed blood culture procedures in three clinical categories: Very low birth weight
(VLBW, <1,500 grams) infants ≤7 days after birth; VLBW infants >7 days after birth; and
infants with birth weight ≥1,500 grams. All analyses were done in SAS 9.4 (Cary, NC).

RESULTS
Study characteristics:

Author Manuscript

During the study period, 987 blood culture orders were placed for 788 infants (Figure 1).
Overall, 961/987 (97.4%) culture orders were associated with a clinician-reported volume:
856 (89.1%) were documented in the clinician’s procedure note and 105 (10.9%) were
obtained by contacting the clinician. During the 12-month period in which inoculant volume
was also assessed by weighing culture bottles, weights were obtained for bottles from
544/559 (97.3%) evaluations. These 544 evaluations included 1,011 culture bottles: 467
aerobic-anaerobic pairs, 72 aerobic bottles only, and 5 anaerobic bottles only.
Of the 987 sepsis evaluations, 703 (71.2%) were performed ≤24 hours after birth and 817
(82.8%) were performed ≤7 days after birth (Table 1). VLBW infants comprised 12.4% of
the study infants, but contributed 27.1% of the culture orders. Sixty infants were evaluated
for sepsis >7 days after birth and 85.0% of them were VLBW.
Blood culture procedure and results:
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Clinicians documented ≥1 mL inoculant in 931/961 (96.9%) sepsis evaluations (Table 2).
Distribution of inoculant source based on birth weight and chronological age of the infant at
the time of evaluation are shown in Supplemental Figure S2 (online). In cultures obtained ≤7
days after birth, 82.2% in VLBW infants were drawn from a central line compared to 7.8%
from larger infants. Insufficient volumes were more frequently reported in VLBW infants
>7 days after birth. Blood cultures from 61 evaluations in 32 infants grew an organism.
Seven were deemed as contaminants by clinical team and managed without antibiotics
(Supplemental Table S3 (online)). Counting the first positive culture from each episode,
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24 patients had 29 episodes of bacteremia. Pathogens were most frequently isolated from
VLBW infants >7 days after birth. Consistent with center policy, follow-up evaluations
performed to confirm resolution of bacteremia mostly consisted of a single culture bottle.
Inoculant volume by weighing:
Among the 544 evaluations in which bottles were weighed, 508 (93.4%) had ≥1 mL total
inoculant volume and 418 (76.8%) had ≥1 mL in at least one bottle (Table 3). Even when
the two bottles sent in an evaluation separately had inoculant volume of <1 mL (n=126), the
total inoculant was often ≥1 mL in 71.4%. Figure 2 shows the distribution of total inoculant
volume between the bottles in each of the 544 blood culture sets. Inaccurate distribution
resulted in <1 mL inoculant in both bottles in 90/544 evaluations, despite the total inoculant
volume being ≥1 mL. Of 1,011 bottles, 427 separate bottles had <1 mL inoculant: 296 had
inoculant volume 0.8 to <1 mL, 105 had 0.5 to <0.8 mL, and 26 had <0.5 mL.
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Pathogen isolation in the 36 evaluations with total inoculant <1 mL was high (6/36),
compared to evaluations with total inoculant ≥1 mL (29/508, p=0.009). Aligned with the
results of the clinician-reported volumes, VLBW infants evaluated >7 days after birth had
lower median volume of inoculant and were more likely to have inoculant volumes between
0.5 to <1 mL (13.5%) compared to VLBW infants evaluated ≤7 days after birth (3.3%) or
compared to non-VLBW infants (4.5%) (p=0.002).
Inoculant volume from procedure note versus by weight:
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There were 539 evaluations for which both clinician-reported inoculant volume and bottle
weight measurement were available. In 351/539 (65.1%), the weighed volume was greater
than or equal to the clinician-reported volume. In 166/539 (30.8%), the weighed volume
was less than the clinician-reported volume by 0.1–0.4 mL, and in 22/539 (4.1%), the
weighed volume was less than the clinician-reported volume by ≥0.5 mL. Figure 3 shows
the distribution of inoculant difference (reported minus weighed inoculant volume) across
increasing documented inoculant volume. When documented inoculant volume was <1
mL (n=5), weighed inoculant volume was even lower. As documented inoculant volume
increased, median difference between documented and weighed inoculant decreased.

Author Manuscript

During the 12 months of bottle weight measurement, only 3 infants had a total inoculant
<0.5 mL. Clinicians in each case reported that the volumes were <1 mL and documented
difficulty obtaining phlebotomy specimens. In each case, the cultures were sterile. The
attending physician discontinued antibiotics after 48 hours in 2 cases – one was a wellappearing term infant evaluated for maternal risk factors and the second was a 29-week
infant on continuous positive airway pressure. The third case involved an extremely preterm
infant evaluated at 39 days of life due to acute clinical decompensation, and the attending
physician opted to administer 7 days of empiric antibiotics.

DISCUSSION
In this single center study, we investigated the oft-heard assertion that the technical
challenges of obtaining neonatal blood culture results in inadequate sampling for this critical
laboratory test. Using a combined approach of standard local guidance, clinician-reported
Pediatr Res. Author manuscript; available in PMC 2021 December 11.
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documentation and weight measurement, we found that ≥1 mL total blood inoculant
was cultured in 93.4% of neonatal sepsis evaluations at our center. We observed good
compliance with local guidelines for number of culture bottles per sepsis evaluation, for
target volume, and for recording details of the evaluation in the medical record in real-time.
Total blood volume cultured per evaluation and volume per bottle was rarely below 0.5
mL. However, we identified issues with dividing blood inoculants accurately between
culture bottles. We also identified the highest incidence of <1 mL inoculant being sent per
evaluation among VLBW infants undergoing sepsis evaluation >7 days after birth, though
86.4% of these evaluations also had ≥1 mL and only one infant had inoculant <0.5 mL.
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Compared to prior reports assessing neonatal blood culture volume, we found a higher
proportion of sepsis evaluations to have adequate total inoculant volume. One study reported
≤0.5 mL inoculant in 55% of aerobic and 58% of anaerobic bottles.(9) Another reported that
40% of neonatal culture bottles contained <0.5 mL inoculant.(18) Connell et al. measured
blood volume in the context of an educational intervention for improved blood culture
collection technique.(7) They defined ≥0.5 mL as adequate neonatal specimen. Prior to
education, 62/95 (65.3%), and after education, 31/38 (81.6%), were deemed adequate. More
recently, in a quality improvement study, Singh et al. reported an improvement in adequate
blood inoculant volume, defined as >0.8 mL, from <4% to 75% of all cultures.(10) In
contrast, we found that 529/539 (98.1%) aerobic and 456/472 (96.6%) anaerobic bottles
that were weighed to determine inoculant volume contained ≥0.5 mL. We speculate that
local center policy targeting 1 mL blood per culture bottle and two blood culture bottles
per evaluation provides a greater margin of error by ‘underfilling’ and may account for the
higher proportion of adequate specimens we found.
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Recommendations for optimal inoculant volume in newborns vary.(20, 24) In the 2019
American Academy of Pediatrics report on early-onset sepsis management, 1 mL inoculant
in a pediatric blood culture bottle is the recommended minimum with consideration for
sending an additional anaerobic bottle.(25) The Infectious Disease Society of America
recommends a weight-based inoculant volume adapted from work by Kellogg et al.: 2
mL blood for infants with weight ≤1,000 grams, 4 mL for infants 1,100–2,000 grams,
and 6 mL for infants >2,000 grams, all inoculated into 1–2 pediatric aerobic bottles.
(26) This is estimated to obtain a maximum of 4.5% of the total blood volume of an
infant, a percent loss that was not associated with hemodynamic changes on continuous
cardiorespiratory monitoring in that study. In contrast, the Clinical and Laboratory Standards
Institute guideline recommends not exceeding 1% of total blood volume, which suggests
that ~0.5 mL inoculant is sufficient for an infant weighing 500 grams.(24) The utility of
anaerobic culture for neonates is controversial and the lack of a pediatric-specific anaerobic
culture bottle is a disadvantage.(27) Our center uses an aerobic-anaerobic pair due to the
following potential benefits: to aid in determination of contaminant species, potential for
selective growth of some facultative species in anaerobic condition, and identification of
obligate anaerobes.(28–32) Most pathogens in this study were facultative anaerobes and
most isolates grew in both culture bottles. One early-onset infection with an obligate
anaerobe, Bacteroides fragilis, was detected in the current study.

Pediatr Res. Author manuscript; available in PMC 2021 December 11.
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Inoculant volume is related to pathogen isolation, with lower volume resulting in decreased
detection. Yet, pathogens were isolated in a significantly higher proportion of evaluations
with <1 mL total inoculant compared to inoculant volume >1 mL (6/36 vs. 29/508,
p=0.009). The apparent contradiction between lower inoculant volume and higher pathogen
isolation has been reported by others and can be eliminated when adjusting for severity of
illness.(3, 18) The heightened efficiency of late-onset evaluations in the NICU compared
to early-onset evaluations in clinical practice is aligned with this preferential selection of
higher-risk infants who are evaluated for late-onset evaluations.(33) In this study, we did not
have data to conduct an adjusted analysis to account for severity of illness. However, 41.6%
of evaluations with <1 mL inoculant and five of the six positive cases in this group occurred
in VLBW infants evaluated >7 days after birth. In contrast to early-onset sepsis evaluation,
which may occur in a well-appearing infant evaluated for maternal risk factors, late-onset
sepsis evaluations among VLBW infants were all performed due to acute clinical instability.
This enriches the chance of true bacteremia with a higher bacterial load that may counter the
effect of a smaller inoculant volume on overall diagnostic yield.
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We identified areas of improvement in this study. Our local policy states, “If insufficient
volume is drawn, inoculate the aerobic culture bottle with the required amount and then
inoculate the anaerobic culture bottle with the remaining volume of blood.” However,
inoculant volume per bottle occasionally remained below 1 mL for both bottles (Figure 2).
For example, 2 mL total inoculant was occasionally distributed as 0.8 mL in one bottle
and 1.2 mL in the second, when ideally, 1 mL would be distributed in each. Imprecision
in transferring small volumes is perhaps not unexpected. Vacuum in the culture bottle
exceeds the volume desired for inoculation and contributes to the challenge of regulating
flow and ensuring appropriate volume transfer. Use of a 3 mL or small volume syringe
when inoculating may aid in precise volume deliverance. Although most pediatric blood
culture bottles are designed for 1–3 mL blood inoculation, it remains unclear if increasing
the dilution of blood:broth by inoculating <1 mL in a single bottle significantly impacts
the likelihood of detecting bacteremia if the total inoculant volume is ≥1 mL.(34) In one
prospective neonatal study, investigators obtained 2 mL blood, inoculated 1 mL into an
aerobic bottle, and divided the remaining 1 mL as 0.5 mL inoculants into an aerobic and
anaerobic pair. A higher detection rate was found with the aerobic-anaerobic pair, which
may suggest that with ≥0.5 mL of inoculant volume, the impact of greater volume per bottle
may not be substantial.(32)
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Differences in adequacy of inoculant volume was associated with the clinical scenario of
VLBW infants being evaluated after >7 days after birth. In contrast, the majority of blood
cultures, in preterm and term infants, were obtained for early-onset sepsis evaluations and
over 95% contained adequate inoculant volumes. The absence of a newly placed central
line for obtaining specimen after the first week of life and the greater frequency of acute
clinical instability in VLBW infants triggering the evaluation may make obtaining adequate
inoculant volumes more challenging. However, even in this group inoculant volumes were
below 0.5 mL in only one infant. Building a dedicated team of skilled clinicians, akin to
what many units have for peripherally inserted central line placement, may be one way
of minimizing attempts at phlebotomy and ensuring adequate inoculant volumes. Preterm
infants requiring intensive care suffer high rates of iatrogenic blood loss in the NICU.(35)
Pediatr Res. Author manuscript; available in PMC 2021 December 11.
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Balancing the tension between iatrogenic blood removal and adequate inoculant volume
remains challenging. Better risk assessment to limit blood culture tests to infants at highest
risk of infection is an obvious first step. In early-onset sepsis evaluations, risk assessment
approaches to improve the efficiency of sepsis evaluation among term and preterm infants
can guide efforts to diagnostic stewardship,(6, 25) and use of cord blood can alleviate the
phlebotomy demands.(36)
Our study has limitations. This is a single-center study, and the clinicians were not blinded
to the study, although the clinicians drawing the specimens, inoculating the specimens,
and weighing the bottles were separate individuals. Our results may not be generalizable
to centers with different patient populations or clinician experience. We do not have
data assigning pathogen recovery to bottle type, and thus we cannot estimate the relative
efficiency of aerobic and anaerobic culture.
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Many microbiological facilities have incorporated automated weighing of blood culture
bottles for adult patients, providing feedback that can both improve technique and inform
decision-making.(8) These techniques are not available for neonatal specimens, but we
found that documenting culture volume, at a minimum, reinforces standards and informs
antibiotic use. We also found ongoing education and intermittent auditing at a unit-level to
be useful tools in maintaining optimal techniques when obtaining blood cultures. Our results
demonstrate that contrary to commonly expressed concern for inadequate inoculant volume
in neonatal blood culture bottles and consequent lack of reliance on negative blood culture
results, adequate inoculant volume could be obtained in most NICU patients undergoing
sepsis evaluations.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.

ACKNOWLEDGEMENTS
Elizabeth Quigley, MSN, Ann Schwoebel, MSN, and all advanced care clinicians and nursing staff of the Intensive
Care Nursery for their support in measuring culture bottles and documenting volume of inoculants. We would also
like to acknowledge Tracy Healy for her guidance in weighing blood culture bottles.
Statement of financial support:
This work was supported in part by the Eunice Kennedy Shriver National Institute of Child Health & Human
Development of the National Institutes of Health grant (K23HD088753).

REFERNCES
Author Manuscript

1. Schelonka RL, Chai MK, Yoder BA, et al. Volume of blood required to detect common neonatal
pathogens. J Pediatr. 1996; 129:275–8 [PubMed: 8765627]
2. Flannery DD, Ross RK, Mukhopadhyay S, et al. Temporal trends and center variation in early
antibiotic use among premature infants. JAMA network open. 2018;1(1):e180164. [PubMed:
30646054]
3. Bouza E, Sousa D, Rodríguez-Créixems M, et al. Is the volume of blood cultured still a significant
factor in the diagnosis of bloodstream infections? J Clin Microbiol. 2007;45(9):2765–9. [PubMed:
17567782]

Pediatr Res. Author manuscript; available in PMC 2021 December 11.

Woodford et al.

Page 9

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

4. Cockerill FR III, Wilson JW, Vetter EA, et al. Optimal testing parameters for blood cultures. Clinical
infectious diseases. 2004;38(12):1724–30. [PubMed: 15227618]
5. Hazen KC, Polage CR. Using Data to Optimize Blood Bottle Fill Volumes and Pathogen Detection:
Making Blood Cultures Great Again. Clinical infectious diseases: an official publication of the
Infectious Diseases Society of America. 2020;70(2):269. [PubMed: 30901027]
6. Puopolo KM, Benitz WE, Zaoutis TE, Committee on Infectious Diseases. Management of neonates
born at≥ 35 0/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis. Pediatrics.
2018;142(6):e20182894. [PubMed: 30455342]
7. Connell TG, Rele M, Cowley D, et al. How reliable is a negative blood culture result? Volume of
blood submitted for culture in routine practice in a children’s hospital. Pediatrics. 2007;119(5):891–
6. [PubMed: 17473088]
8. Khare R, Kothari T, Castagnaro J, et al. Active monitoring and feedback to improve blood culture
fill volumes and positivity across a large integrated health system. Clinical Infectious Diseases.
2020;70(2):262–8. [PubMed: 30873522]
9. Neal PR, Kleiman MB, Reynolds JK, et al. Volume of blood submitted for culture from neonates. J
Clin Microbiol. 1986;24(3):353–6. [PubMed: 3760131]
10. Singh MP, Kumar BV, Kiran, et al. The practice of blood volume submitted for culture in
a neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2020;105(6):600. [PubMed:
32198199]
11. van Ingen J, Hilt N, Bosboom R. Education of phlebotomy teams improves blood volume in blood
culture bottles. J Clin Microbiol. 2013;51(3):1020–1. [PubMed: 23269730]
12. Piantino JH, Schreiber MD, Alexander K, et al. Culture negative sepsis and systemic inflammatory
response syndrome in neonates. NeoReviews. 2013;14(6):e294–305.
13. Simonsen KA, Anderson-Berry AL, Delair SF, et al. Early-onset neonatal sepsis. Clin Microbiol
Rev. 2014;27(1):21–47. [PubMed: 24396135]
14. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the
United States, 2005–2008. Pediatr Infect Dis J. 2011;30(11):937. [PubMed: 21654548]
15. Cantey JB, Baird SD. Ending the culture of culture-negative sepsis in the neonatal ICU. Pediatrics.
2017;140(4).
16. Puopolo KM, Mukhopadhyay S, Hansen NI, et al. Identification of extremely premature infants at
low risk for early-onset sepsis. Pediatrics. 2017;140(5).
17. Schulman J, Dimand RJ, Lee HC, et al. Neonatal intensive care unit antibiotic use. Pediatrics.
2015;135(5):826–33. [PubMed: 25896845]
18. Jawaheer G, Neal TJ, Shaw NJ. Blood culture volume and detection of coagulase negative
staphylococcal septicaemia in neonates. Archives of Disease in Childhood-Fetal and Neonatal
Edition. 1997;76(1):F57–8. [PubMed: 9059190]
19. Kellogg JA, Ferrentino FL, Goodstein MH, et al. Frequency of low level bacteremia in infants from
birth to two months of age. Pediatr Infect Dis J. 1997;16(4):381–5. [PubMed: 9109140]
20. Lancaster DP, Friedman DF, Chiotos K, et al. Blood volume required for detection of low levels
and ultralow levels of organisms responsible for neonatal bacteremia by use of Bactec Peds Plus/F,
Plus Aerobic/F medium, and the BD Bactec FX system: an in vitro study. J Clin Microbiol.
2015;53(11):3609–13. [PubMed: 26292299]
21. Tzialla C, Manzoni P, Achille C, et al. New diagnostic possibilities for neonatal sepsis. Am J
Perinatol. 2018;35(06):575–7. [PubMed: 29695000]
22. Trudnowski RJ, Rico RC. Specific gravity of blood and plasma at 4 and 37 C. Clin Chem.
1974;20(5):615–6. [PubMed: 4826961]
23. Cantey JB, Wozniak PS, Sánchez PJ. Prospective surveillance of antibiotic use in the neonatal
intensive care unit: results from the SCOUT study. Pediatr Infect Dis J. 2015;34(3):267–72.
[PubMed: 25191849]
24. Bard JD, TeKippe EM. Diagnosis of bloodstream infections in children. J Clin Microbiol.
2016;54(6):1418–24. [PubMed: 26818669]
25. Puopolo KM, Benitz WE, Zaoutis TE. Management of Neonates Born at ≤34 6/7 Weeks’ Gestation
With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics. 2018;142(6):e20182896.
[PubMed: 30455344]
Pediatr Res. Author manuscript; available in PMC 2021 December 11.

Woodford et al.

Page 10

Author Manuscript
Author Manuscript

26. Kellogg JA, Manzella JP, Bankert DA. Frequency of low-level bacteremia in children from birth to
fifteen years of age. J Clin Microbiol. 2000;38(6):2181–5. [PubMed: 10834973]
27. Mukhopadhyay S, Puopolo KM. Relevance of Neonatal Anaerobic Blood Cultures: New
Information for an Old Question. Journal of the Pediatric Infectious Diseases Society.
2018;7(3):e126. [PubMed: 29165632]
28. Messbarger N, Neemann K. Role of anaerobic blood cultures in neonatal bacteremia. Journal of the
Pediatric Infectious Diseases Society. 2018;7(3):e65–9. [PubMed: 29165580]
29. Shoji K, Komuro H, Watanabe Y, et al. The utility of anaerobic blood culture in detecting
facultative anaerobic bacteremia in children. Diagn Microbiol Infect Dis. 2013;76(4):409–12.
[PubMed: 23747032]
30. Zaidi AK, Knaut AL, Mirrett S, et al. Value of routine anaerobic blood cultures for pediatric
patients. J Pediatr. 1995;127(2):263–8. [PubMed: 7636652]
31. Riley JA, Heiter BJ, Bourbeau PP. Comparison of recovery of blood culture isolates from two
BacT/ALERT FAN aerobic blood culture bottles with recovery from one FAN aerobic bottle and
one FAN anaerobic bottle. J Clin Microbiol. 2003;41(1):213–7. [PubMed: 12517851]
32. Yaacobi N, Bar-Meir M, Shchors I, et al. A prospective controlled trial of the optimal volume for
neonatal blood cultures. Pediatr Infect Dis J. 2015;34(4):351–4. [PubMed: 25764096]
33. Schulman J, Benitz WE, Profit J, et al. Newborn Antibiotic Exposures and Association With
Proven Bloodstream Infection. Pediatrics. 2019;144(5):e20191105. [PubMed: 31641017]
34. Kennaugh JK, Gregory WW, Powell KR, et al. The effect of dilution during culture on detection of
low concentrations of bacteria in blood. Pediatr Infect Dis J. 1984;3(4):317–8.
35. Counsilman CE, Heeger LE, Tan R, et al. Iatrogenic blood loss in extreme preterm infants due
to frequent laboratory tests and procedures. The Journal of Maternal-Fetal & Neonatal Medicine.
2019:1–6.
36. Baer VL, Lambert DK, Carroll PD, et al. Using umbilical cord blood for the initial blood
tests of VLBW neonates results in higher hemoglobin and fewer RBC transfusions. Journal of
Perinatology. 2013;33(5):363–5. [PubMed: 23047426]

Author Manuscript
Author Manuscript
Pediatr Res. Author manuscript; available in PMC 2021 December 11.

Woodford et al.

Page 11

Author Manuscript

Article Impact:
What is the key message of your article?
•

Current recommendations for adequate inoculant volume for blood cultures
are met in a majority of neonates.

•

Areas of improvement include preterm late-onset sepsis evaluations and
distribution techniques during inoculation.

What does it add to the existing literature?
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•

Clinicians express concern about the unreliability of neonatal blood cultures
because of inadequate inoculant volume.

•

We investigated over 900 evaluations and found >90% of evaluations have ≥1
mL inoculant.

What is the impact?
•

Monitoring adequacy of blood culture technique can identify areas of
improvement and may allay concerns about blood culture reliability.
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In this flow diagram, we describe the study design and inoculant volume determination
methods during the study period.
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Figure 2:

In this stacked bar graph, each of the 544 blood culture evaluations in which bottles were
weighed are shown. The x-axis numbers each evaluation and is arranged by total inoculant
volume, from lowest volume at 1 to highest at 544. The y-axis shows the blood volume in
mL by weight. Total height of each bar corresponds to the total inoculant volume for that
evaluation. Some bars consist of a light portion and a dark portion. The height of the dark
portion corresponds to the inoculant volume in the aerobic bottle and the height of the light
portion corresponds to the inoculant volume in the anaerobic bottle. For evaluations in which
only one type of bottle was sent, the bar color corresponds with the type of bottle.
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Figure 3:
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This box and whisker plot shows the median distribution of difference between reported and
weighed inoculant volume across three categories of reported inoculant volume (<1 mL, 1 to
<2 mL and 2 or more mL). Median difference greater than zero between reported and weight
inoculant when <2 mL was documented suggests reported volumes were more frequently
more than weighed volumes. In contrast, among the majority of the cultures (n=457) where
2 or more mL were reported, weighed volume was higher or the same as the reported
inoculant volume, giving a median difference less than zero.
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251 (31.9)
84 (10.7)
57 (7.2)
24 (3.0)
415 (52.7)
310 (39.3)
5 (3–19.5)

Black/non-Hispanic

Hispanic

Asian

Other/unknown

Male sex, n (%)

Mode of delivery, Cesarean section, n (%)

Length of hospital stay (days), median (IQR)

60 (7.6)

Infants with at least one culture at >7 days of age, n (%)

51 (52.0)

2 (1–3)

1.4 (1.0–45.0)

267

68.5 (38–100)

58 (59.2)

46 (46.9)

4 (4.1)

4 (4.1)

11 (11.2)

45 (45.9)

34 (34.7)

9 (1.3)

1 (1–1)

1.4 (0.9–3.2)

720

4 (2–13)

252 (36.5)

369 (53.5)

20 (2.9)

53 (7.7)

73 (10.6)

206 (29.9)

338 (49.0)

3018 (733)

53 (7.7)

37.7 (3.0)

BW ≥1500g
n = 690

Abbreviations: VLBW – very low birth weight, BW – birth weight, SD – standard deviation, IQR – interquartile range

1 (1–1)

Age at first blood culture (hours), median (IQR)

Total number of culture orders per infant, median (IQR)

987
1.4 (0.9–3.5)

Total number of cultures contributed to study, n

Blood culture characteristics

372 (47.2)

White/non-Hispanic

Race/ethnicity, n (%)

96 (98.0)

149 (18.9)
2765 (967)

<33 weeks, n (%)

Birth weight (grams), mean (SD)

982 (320)

27.5 (2.7)

36.5 (4.5)

Gestational age at birth, mean (SD)

VLBW, BW <1500g
n = 98

All infants
n = 788
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Study patient characteristics
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b

26 (2.6)

Missing documentation

47 (4.8)

Peripherally inserted central catheter

25 (3.5)
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1/5 (9.3)

5/10 (50.0)

10 (1.4)

20/664 (3.0)

8/47 (17.0)

1/48 (2.1)

48 (30.0)

0

11/105 (10.5)

2 (1.3)

49 (30.6)

109 (68.1)

43 (26.9)

7 (4.4)

5 (3.1)

105 (65.6)

2 (1.3)

11 (6.9)

43 (26.9)

104 (65.0)

VLBW & culture obtained >7 days
n = 160

0.13

<0.001

<0.001

0.38

<0.001

<0.001

0.24

0.006

<0.001

<0.001

p-value

Assessment of inoculate volume adequacy based on documented note, e.g. 2 mL and 2 bottles sent, the assumption was that each bottle contained ≥1 mL; if 1.8 mL sent in 2 bottles, then categorized as <1
mL per bottle.

b

All blood culture orders for infants with birth weight >1500 grams were drawn at ≤7 days after birth except 10 orders (among 9 infants) drawn >7 days.

a

1/2 (50.0)

1/3 (33.3)

3 (2.8)

0

4/18 (22.2)

3 (2.8)

16 (15.0)

88 (82.2)

3 (2.8)

85 (79.4)

1 (0.9)

18 (16.8)

5 (4.7)

1 (0.9)

15 (14.0)

86 (80.4)

VLBW & culture obtained ≤7 days
n = 107

Abbreviations: VLBW – very low birth weight, CoNS – Coagulase negative staphylococci

7/61 (11.5)
10/54 (18.5)

CoNS (not treated as contaminant)

61 (6.2)

20/787 (2.5)

Contaminants

Orders growing any organism, n (%)

Missing documentation

83/664 (12.5)

30 (3.0)

More than 2 attempts at phlebotomy, n (%)

98/787 (12.5)

135 (13.7)

Aerobic/Anaerobic alone

Missing documentation

70 (9.7)

822 (83.3)

625 (86.8)

1 (0.1)

53 (7.4)

2 (0.3)

664 (92.2)

19 (2.6)

18 (2.5)

66 (9.2)

617 (85.7)

Birth weight
a
>1500 grams
n = 720

Aerobic-Anaerobic pair

Bottles sent, n (%)

145 (14.7)

8 (0.8)

Umbilical line

Peripheral arterial line

Phlebotomy

787 (79.7)

30 (3.0)

Documented <1 mL per bottle sent

Site for specimen draw, n (%)

124 (12.6)

807 (81.8)

1 mL documented and 1 bottle sent

2 mL documented and 2 bottles sent

Clinician-reported total volume per order, n (%)

Total
n = 987
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a

10 (1.9)
472

<0.5 mL in aerobic bottle, n (%)

a
Anaerobic culture bottles , n

16 (3.4)

<0.5 mL in anaerobic bottle, n (%)
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0 (0)

25 (47.2)

28 (52.8)

1.0 (0.9–1.2)

53

1 (1.7)

30 (50.9)

28 (47.5)

1.0 (0.8–1.1)

59

43 (71.7)

1 (1.7)

2 (3.3)

57 (95.0)

2.0 (1.7–2.1)

60

VLBW & culture obtained ≤7 days

5 (7.0)

34 (47.9)

32 (45.1)

1.0 (0.9–1.1)

71

2 (2.0)

48 (47.1)

52 (51.0)

1.0 (0.8–1.2)

102

68 (65.4)

1 (1.0)

14 (13.5)

89 (85.6)

1.8 (1.2–2.1)

104

VLBW & culture obtained >7 days

When inoculant volume was <1 to 0.5 mL, 156/225 (69%) aerobic bottles and 140/176 (80%) anaerobic bottles had volume of 0.8 to <1 mL.

b

Blood culture evaluation includes all culture bottles sent per evaluation and may include one bottle or a pair of bottles. Inoculant volume per bottle is shown separately.

a

Abbreviations: VLBW – very low birth weight, IQR – interquartile range

11 (3.2)

117 (33.6)

176 (37.3)

<1 to 0.5 mL in anaerobic bottle , n (%)

b

220 (63.2)

280 (59.3)

≥1 mL in anaerobic bottle, n (%)

1.1 (1.0–1.2)

1.0 (0.9–1.2)

Volume (mL) in anaerobic bottle, median (IQR)

348

7 (1.9)

147 (38.9)

225 (41.7)

<1 to 0.5 mL in aerobic bottle , n (%)

b

224 (59.3)

304 (56.4)

≥1 mL in aerobic bottle, n (%)

1.1 (0.9–1.2)

378

1.0 (0.9–1.2)

539

307 (80.8)

1 (0.3)

17 (4.5)

362 (95.3)

2.1 (1.9–2.3)

Volume (mL) in aerobic bottle, median (IQR)

Aerobic culture bottles , n

a

418 (76.8)

3 (0.5)

<0.5 mL per evaluation, n (%)

At least one bottle with ≥1 mL, n (%)

33 (6.1)

508 (93.4)

<1 to 0.5 mL per evaluation, n (%)

2.0 (1.8–2.3)

≥1 mL per evaluation, n (%)

380

544

Total volume (mL) per evaluation, median (IQR)

Blood culture evaluation , n

Birth weight
>1500 grams

Total
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Blood inoculant volume from weighing bottles

0.09

0.02

0.01

0.004

0.99

0.11

0.11

0.03

0.003

0.32

0.002

0.002

<0.001

p-value
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